MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ejhf.2851

Медицинская библиотека · European journal of heart failure · 2023

Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial.

Butt Jawad H, Claggett Brian L, Miao Zi M, Jering Karola S, Sim David, van der Meer Peter, Ntsekhe Mpiko, Amir Offer, Cho Myeong-Chan, Carrillo-Calvillo Jorge, Núñez Julio E, Cadena Alberto, Kerkar Prafulla, Maggioni Aldo P, Steg Philippe G, Granger Christopher B, Mann Douglas L, Merkely Béla, Lewis Eldrin F, Solomon Scott D, Zhou Yinong, Køber Lars, Braunwald Eugene, McMurray John J V, Pfeffer Marc A

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

AIM: The globalization of clinical trials has highlighted geographic differences in patient characteristics, treatments, and outcomes. We examined these differences in PARADISE-MI.

METHODS AND

RESULTS

Overall, 23.0% were randomized in Eastern Europe/Russia, 17.5% in Western Europe, 12.2% in Southern Europe, 10.1% in Northern Europe, 12.0% in Latin America (LA), 9.3% in North America (NA), 10.0% in East/South-East Asia and 5.8% in South Asia (SA). Those from Asia, particularly SA, were different from patients enrolled in the other regions, being younger and thinner. They also differed in terms of comorbidities (high prevalence of diabetes and low prevalence of atrial fibrillation), type of myocardial infarction (more often ST-elevation myocardial infarction), and treatment (low rate of primary percutaneous coronary intervention). By contrast, patients from LA did not differ meaningfully from those randomized in Europe or NA. Use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (34.8%) and beta-blockers (65.5%) was low in SA, whereas mineralocorticoid receptor antagonist use was lowest in NA (22%) and highest in Eastern Europe/Russia (53%). Rates of the primary composite outcome of cardiovascular death or incident heart failure varied two-fold among regions, with the lowest rate in SA (4.6/100 person-years) and the highest in LA (9.2/100 person-years). Rates of incident heart failure varied almost six-fold among regions, with the lowest rate in SA (1.0/100 person-years) and the highest in Northern Europe (5.9/100 person-years). The effect of sacubitril/valsartan was not modified by region.

CONCLUSION

In PARADISE-MI, there were substantial regional differences in patient characteristics, treatments and outcomes. Although the generalizability of these findings to a 'real-world' unselected population may be limited, these findings underscore the importance of considering both regional and within-region differences when designing global clinical trials.

Для цитирования: Butt Jawad H, Claggett Brian L, Miao Zi M, Jering Karola S, Sim David, van der Meer Peter, Ntsekhe Mpiko, Amir Offer, Cho Myeong-Chan, Carrillo-Calvillo Jorge, Núñez Julio E, Cadena Alberto, Kerkar Prafulla, Maggioni Aldo P, Steg Philippe G, Granger Christopher B, Mann Douglas L, Merkely Béla, Lewis Eldrin F, Solomon Scott D, Zhou Yinong, Køber Lars, Braunwald Eugene, McMurray John J V, Pfeffer Marc A. Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trial.. European journal of heart failure. 2023. DOI: 10.1002/ejhf.2851.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.